TENAX THERAPEUTICS, INC.
Profile
Company Names
TENAX THERAPEUTICS, INC.
OXYGEN BIOTHERAPEUTICS, INC.
Addresses
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC 27517
ONE COPLEY PARKWAY, ONE COPLEY PARKWAY, MORRISVILLE, NC 27560
ONE COPLEY PARKWAY, SUITE 490, MORRISVILLE, NC 27560
2530 MERIDIAN PARKWAY, 3RD FLOOR, DURHAM, NC 27713
Phone Numbers
919-855-2100
(919) 855-2100
714-427-6363
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$141,753,943.00
Number of Funding Rounds:
10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2024-08-08
$99,681,169.00
$174,999,993.00
$75,318,824.00
Equity
9
2022-05-17
$8,000,000.00
$8,000,000.00
$0.00
8
2021-07-08
$9,999,998.00
$9,999,998.00
$0.00
7
2020-07-08
$5,173,587.00
$5,173,587.00
$0.00
6
2020-03-13
$317,167.00
$317,167.00
$0.00
5
2013-11-13
$6,579,122.00
$6,579,122.00
$0.00
Equity
4
2013-08-22
$4,600,000.00
$4,600,000.00
$0.00
Equity
3
2013-07-23
$52,900.00
$52,900.00
$0.00
Equity
2
2013-02-27
$2,100,000.00
$2,100,000.00
$0.00
Equity
1
2009-06-08
$5,250,000.00
$21,000,000.00
$15,750,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JUNE
ALMENOFF
DIRECTOR
STEVEN
BOYD
DIRECTOR
TIGER GLOBAL FB PARTNERS, LLC
| ARMISTICE CAPITAL FUND LP
| ARMISTICE CAPITAL FUND OFFSHORE LTD.
| REVERSE MORTGAGE INVESTMENT TRUST INC.
| ARMISTICE CAPITAL OFFSHORE FUND LTD.
| EYEGATE PHARMACEUTICALS INC
| AYTU BIOSCIENCE, INC
| TETRAPHASE PHARMACEUTICALS INC
| TREBUCHET GRANITE ONSHORE FUND, LP
| TENAX THERAPEUTICS, INC.
| VARSITY EMERGENCY CARE HOLDINGS, LLC
MICHAEL
DAVIDSON
DIRECTOR
ANTHONY
DITONNO
DIRECTOR, EXECUTIVE OFFICER
DECLAN
DOOGAN
DIRECTOR
JOHN
KELLEY
EXECUTIVE OFFICER
KEITH
MAHER
DIRECTOR
GERALD
T.
PROEHL
DIRECTOR
CHRIS
A.
RALLIS
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-08-08
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
2020-07-08
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
2020-03-13
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
$1,000,001 - $5,000,000
Equity
2013-11-13
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
$1,000,001 - $5,000,000
Equity
2013-08-22
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
$1,000,001 - $5,000,000
Equity
2013-07-23
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
$1 - $1,000,000
Equity
2013-02-27
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
NO REVENUES
Equity
2009-06-08
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MELIXIA SA
NONE
NONE
NONE
MTS FINANCE LTD.
NONE

